48,474
edits
(One intermediate revision by the same user not shown) | |||
Line 46: | Line 46: | ||
*Non-bilharzial SCC (NBSCC). | *Non-bilharzial SCC (NBSCC). | ||
Characteristics of NBSCC:<ref name=pmid27547458> | Characteristics of NBSCC:<ref name=pmid27547458/> | ||
*Prevalance ~2-5% of bladder tumours (in Western countries).<ref>URL: [https://www.myvmc.com/diseases/bladder-cancer-squamous-cell-carcinoma-of-the-bladder/ https://www.myvmc.com/diseases/bladder-cancer-squamous-cell-carcinoma-of-the-bladder/]. Accessed on: 14 February 2018.</ref> | *Prevalance ~2-5% of bladder tumours (in Western countries).<ref>URL: [https://www.myvmc.com/diseases/bladder-cancer-squamous-cell-carcinoma-of-the-bladder/ https://www.myvmc.com/diseases/bladder-cancer-squamous-cell-carcinoma-of-the-bladder/]. Accessed on: 14 February 2018.</ref> | ||
*Usually high-grade. | *Usually high-grade. | ||
*Typical patient 7th decade. | *Typical patient 7th decade. | ||
**Fifth decade for BSCC | **Fifth decade for BSCC | ||
*Present with | *Present with hematuria without irritative bladder symptoms. | ||
*Risk factors: indwelling catheters, chronic inflammation/irritants. | *Risk factors: indwelling catheters, chronic inflammation/irritants. | ||
edits